POZ Community Forums

Meds, Mind, Body & Benefits => Questions About Treatment & Side Effects => Topic started by: buginme2 on February 10, 2012, 01:06:35 am

Title: PN treatment rejected by the FDA
Post by: buginme2 on February 10, 2012, 01:06:35 am
There has been a lot of talk on here about Periferal Nueropathy.   fDa announced they rejected a new treatment for HIV PN?  Vote was 12-0.
Article says that PN affects 40% of HIV patients.

http://www.medpagetoday.com/HIVAIDS/HIVAIDS/31109
Title: Re: PN treatment rejected by the FDA
Post by: aztecan on February 10, 2012, 09:23:57 am
I think Ray was involved in a study for this.

Sad the pharma's results were so erratic.

HUGS,

Mark
Title: Re: PN treatment rejected by the FDA
Post by: J.R.E. on February 10, 2012, 10:53:38 am
I think Ray was involved in a study for this.

Sad the pharma's results were so erratic.

HUGS,

Mark


Yes I was ...  :P   Hard to believe that was 5 years ago. NeurogesX was the company doing the study.



http://forums.poz.com/index.php?topic=8243.msg145639#msg145639


http://clinicaltrials.gov/ct/show/NCT00321672?order=1

I also read somewhere recently, that electrical stimulation to the spine may help with nueropathy



Ray
Title: Re: PN treatment rejected by the FDA
Post by: J.R.E. on February 10, 2012, 11:02:12 am
Here it is....


http://www.aidsmeds.com/articles/hiv_spinal_neuropathy_1667_21869.shtml


Ray